Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001675530 | SCV001894136 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002073174 | SCV002367337 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2022-11-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502019 | SCV002808832 | likely benign | Alagille syndrome due to a JAG1 point mutation; Tetralogy of Fallot; Deafness, congenital heart defects, and posterior embryotoxon; Charcot-Marie-Tooth disease, axonal, Type 2HH | 2022-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003163789 | SCV003855105 | likely benign | Cardiovascular phenotype | 2023-01-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004551971 | SCV004795462 | likely benign | JAG1-related disorder | 2022-05-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |